Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US62855J1043
Ticker MYGN
Company MYRIAD GENETICS
Currency $
Price
Aware Investor Index (AII) 0.1563
Recommendation HOLD
P/E 22.47
ROE 11.63 %
Capitalization 2,520,000,000 $
Dividend Yield 0.00 %
P/S 3.26
AII Position 428
P/E Position 308
ROE Position 320
Capitalization Position 629
Dividend Yield Position 594
Sales 772,600,000 $
10-Year Average Earnings 112,174,300 $
Shares Outstanding 72,000,000
Equity 964,900,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
MYRIAD GENETICS Investor Relations Web Site http://investor.myriad.com







Sales:

YEAR MONTH AMOUNT
2018 6 772,600,000.00 $
2017 6 769,900,000.00 $
2016 6 740,500,000.00 $
2015 6 722,500,000.00 $
2014 6 778,216,000.00 $
2013 6 613,165,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 6 131,100,000.00 $
2017 6 20,500,000.00 $
2016 6 117,200,000.00 $
2015 6 79,800,000.00 $
2014 6 176,225,000.00 $
2013 6 147,139,000.00 $
2012 6 112,151,000.00 $
2011 6 100,710,000.00 $
2010 6 152,303,000.00 $
2009 6 84,615,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 6 964,900,000.00 $
2017 6 768,000,000.00 $
2016 6 739,600,000.00 $
2015 6 661,700,000.00 $
2014 6 718,998,000.00 $
2013 6 728,594,000.00 $
2012 6 635,660,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 6 72,000,000
2017 6 68,800,000
2016 6 72,400,000
2015 6 74,500,000
2014 6 78,182,000
2013 6 83,327,000
2012 6 86,465,000

 












Bloomberg News for MYRIAD GENETICS:



Google News for MYRIAD GENETICS:

Seeking Alpha - 7 May 2019
Myriad Genetics: Buy, Sell Or Hold?
Myriad Genetics (MYGN) IPO'd in 1995 and is a Salt Lake City, Utah-based molecular diagnostics company. The company's products help ...
Zacks.com
Myriad Genetics (MYGN) Sets New 52-Week Low at $25.85
Myriad Genetics, Inc. (NASDAQ:MYGN)'s share price reached a new 52-week low during mid-day trading on Friday . The company traded as ...
Yahoo Finance
Myriad Genetics (MYGN) PT Lowered to $32 at Needham & Company
Needham & Company analyst Stephen Unger lowered the price target on Myriad Genetics (NASDAQ: MYGN) to $32.00 (from $41.00) while ...
GlobeNewswire (press release)
Myriad Genetics (MYGN) Earnings Expected to Grow: Should You ...
Wall Street expects a year-over-year increase in earnings on higher revenues when Myriad Genetics (MYGN) reports results for the quarter ...
Rockland Register - 14 hours ago
Myriad Genetics to Present at Two Upcoming Healthcare Conferences
SALT LAKE CITY, May 01, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and ...
Williams Review
2 Stocks Attracting Lots Of Interest: Pattern Energy Group Inc. (PEGI ...
Myriad Genetics, Inc. (NASDAQ:MYGN) shares depreciated -0.53% over the last trading period, taking overall 5-day performance up to -4.62%.
Mayfield Recorder
Myriad Genetics, Inc. (NasdaqGS:MYGN), Yara International ASA ...
Investors may be interested in viewing the Gross Margin score on shares of Myriad Genetics, Inc. (NasdaqGS:MYGN). The name currently has ...
Riverdale Standard
Closely Watching the Magic Formula & Quant Scores for Myriad ...
Myriad Genetics, Inc. (NasdaqGS:MYGN) has a current MF Rank of 8325. Developed by hedge fund manager Joel Greenblatt, the intention of ...
StreetInsider.com - 5 days ago
Edgewell Personal Care Company (EPC), Myriad Genetics, Inc ...
For shares of Myriad Genetics, Inc. (NASDAQ: MYGN), there are currently ratings available from 10 different stock market analysts who have all ...
Rockland Register
These 2 Stocks Are Circling the Drain: Myriad Genetics, Inc. (MYGN ...
The price of Myriad Genetics, Inc. (NASDAQ:MYGN) went down by $-0.26 now trading at $26.58. Their shares witnessed a 2.15% increase from ...


Back